| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
1 company
Mary Reumuth last filed a Form 4 in October 2025, as Chief Financial Officer at KALA. Mary Reumuth's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Mary Reumuth a strong insider score of 77/100, based on 14 past trades. Over a 12-month horizon, 78.6% of those trades were profitable, with an average 12-month return of +48.2%.
At the last filing, the largest reported position was 28,906 shares of KALA. The KALA filings lean toward selling, a net 66,178 shares.
Mary Reumuth has 24 Form 4 filings on record from July 2017 to October 2025, all as Chief Financial Officer at Kala Bio (KALA), 2017–2025.
The 44 reported transactions were 14 open-market sales, 10 option or other derivative awards, 8 stock awards and 8 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 13 sales worth about $144K.
The largest open-market sale was 33,197 shares of KALA at an average $0.83 on October 23, 2025, about $28K. Twelve months later KALA was down 100%.
None of the 7 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from October 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 33,197 | $0.83 | $27,543.84 | -53.5% | -22.9% | -99.5% | |
| Jun 24, 2025 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 3,631 | $4.01 | $14,560.31 | -5.5% | +363.8% | -25.0% | |
| Jun 3, 2025 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 2,850 | $3.74 | $10,659.00 | -4.2% | +198.0% | -45.5% | |
| Jan 6, 2025 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 1,706 | $7.63 | $13,016.78 | -2.4% | -50.3% | -91.3% | |
| Jun 26, 2024 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 4,163 | $4.75 | $19,774.25 | -6.5% | +20.0% | +14.2% | |
| May 31, 2024 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 1,786 | $6.09 | $10,876.74 | -2.7% | -12.4% | -44.6% | |
| Jan 4, 2024 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 1,227 | $6.74 | $8,269.98 | -1.8% | +11.1% | +13.3% | |
| Jan 4, 2023 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 60 | $28.54 | $1,712.40 | -0.5% | -67.0% | -83.4% | |
| Oct 26, 2022 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 194 | $6.51 | $1,262.94 | -7.4% | +168.5% | +18.0% | |
| Jun 27, 2022 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 2,613 | $0.37 | $966.81 | -2.0% | -37.2% | -11.6% |